Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPARγ/NF-κB/IL-6 signaling pathway

Traumatic brain injury (TBI) is the major cause of high mortality and disability rates worldwide. Pioglitazone is an activator of peroxisome proliferator-activated receptor-gamma (PPARγ) that can reduce inflammation following TBI. Clinically, neuroinflammation after TBI lacks effective treatment. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yongbing, Jiang, Xue, Deng, Xiaoyan, Chen, Hong, Xu, Jie, Zhang, Zhaosi, Liu, Geli, Yong, Zhu, Yuan, Chengfu, Sun, Xiaochuan, Wang, Changdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083749/
https://www.ncbi.nlm.nih.gov/pubmed/32215295
http://dx.doi.org/10.1016/j.gendis.2019.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083749/
https://www.ncbi.nlm.nih.gov/pubmed/32215295
http://dx.doi.org/10.1016/j.gendis.2019.05.002

Ejemplares similares